Controlling magnesium corrosion and degradation-regulating mineralization using matrix GLA protein

Area of Science:

• Biomaterials Science
• Biomedical Engineering
• Tissue Engineering

Background:

• Magnesium (Mg) alloys offer biodegradability and biocompatibility for medical implants.
• Spontaneous degradation of Mg in vivo leads to calcium phosphate deposition, causing pathogenic calcification after metal absorption.

Purpose of the Study:

• To investigate the efficacy of matrix GLA protein (MGP) in locally inhibiting Mg-based implant mineralization.
• To assess MGP's potential to prevent calcification associated with Mg alloy degradation.

Main Methods:

• Exposing Mg to MGP-overexpressing mammalian cells in vitro.
• Implanting Mg rods in collagen scaffolds with MGP-overexpressing cells in a mouse intramuscular model for 4 and 6 weeks.
• Utilizing microtomography, electron dispersive X-ray spectroscopy, and histology for assessment.

Main Results:

• Reduced calcium and phosphorus deposition on Mg surfaces when MGP was present.
• Significantly lower mineral volume around Mg rods in the MGP group in vivo.
• Increased Mg rod volume loss in the MGP group, indicating enhanced corrosion without mineral shielding.

Conclusions:

• Local MGP exposure effectively modulates Mg implant corrosion by inhibiting mineralization.
• This study is the first to demonstrate biomolecule-mediated control of Mg implant corrosion.
• Findings suggest potential applications for MGP in designing advanced endovascular stents and orthopedic devices.